SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A - Offering Statement [Regulation A]:
SEC Accession No. 0001493152-21-018997
Filing Date
2021-08-09
Accepted
2021-08-09 09:15:41
Documents
10

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A  
1 primary_doc.xml 1-A 10168
2 partiiandiii.htm PART II AND III 1958768
3 ex1-1.htm EX1A-1 UNDR AGMT 142874
4 ex11-1.htm EX1A-11 CONSENT 5080
5 form1-a_001.jpg GRAPHIC 10643
6 form1-a_003.jpg GRAPHIC 27637
7 form1-a_004.jpg GRAPHIC 14193
8 form1-a_006.jpg GRAPHIC 14584
9 image_003.jpg GRAPHIC 19053
10 ex1-1_001.jpg GRAPHIC 28087
  Complete submission text file 0001493152-21-018997.txt   2276066
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 1-A | Act: 33 | File No.: 024-11602 | Film No.: 211154986
SIC: 2834 Pharmaceutical Preparations